MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and
comprehensive loss
-$11,922K
(-26.31%↓ Y/Y)
Interest income
$874K
(-19.07%↓ Y/Y)
Loss from operations
-$11,829K
(-23.01%↓ Y/Y)
Interest expense
$967K
(7.09%↑ Y/Y)
Commercial
$4,626K
(142.07%↑ Y/Y)
Research and
development, net of tax...
$3,940K
(-0.58%↓ Y/Y)
General and
administrative
$3,263K
(-12.80%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)